title: Studies of ERA/BHK-21 rabies vaccine in skunks and mice.
abstract: ERA rabies vaccine virus grown in BHK-21 13S cells (ERA/BHK-21) and street rabies virus were titrated in mice by intracerebral, intranasal and intramuscular inoculation. Mice were also given undiluted ERA/BHK-21 in baits. Skunks were given undiluted ERA/BHK-21 in baits and by intramuscular, intranasal and intestinal inoculation. Virus neutralizing antibody titers against rabies virus were measured over a three month observation period. The surviving skunks were challenged by intramuscular inoculation with rabies street virus from a skunk salivary gland suspension. When titrated in mice, ERA/BHK-21 had titers of 10(7.0), 10(5.2) and 10(3.9) median lethal doses per mL by the intracerebral, intranasal and intramuscular routes, respectively. All skunks (8/8) inoculated intranasally developed paralytic rabies by 12 days after exposure to ERA/BHK-21 virus. None of the skunks that developed vaccine-induced rabies had infectious virus in the submandibular salivary glands. Vaccine-induced rabies also occurred in 1/8 skunks in the intramuscularly inoculated group and in 1/8 in the intestinally inoculated group. The survival rates of challenged skunks in the various groups were as follows: intramuscular, 7/7; intestinal, 2/7; bait, 0/8; and control, 0/8. These results indicate that ERA/BHK-21 virus has a significant residual pathogenicity in mice and in skunks by some routes of inoculation. Skunks given vaccine intramuscularly were protected against challenge, while those skunks given the vaccine in baits were not.
authors.affiliation: Agriculture Canada, Animal Diseases Research Institute, NEPEAN, Ontario.
authors.forename: N D
authors.initials: ND
authors.lastname: Tolson
authors.forename: K M
authors.initials: KM
authors.lastname: Charlton
authors.forename: K F
authors.initials: KF
authors.lastname: Lawson
authors.forename: J B
authors.initials: JB
authors.lastname: Campbell
authors.forename: R B
authors.initials: RB
authors.lastname: Stewart
mesh_terms: D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002335:Carnivora; D004384:Duodenoscopy / Q000662:veterinary; D005260:Female; D005455:Fluorescent Antibody Technique; D007273:Injections, Intramuscular / Q000662:veterinary; D008297:Male; D012889:Mephitidae; D051379:Mice; D011818:Rabies / Q000517:prevention & control / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000633:toxicity; D011820:Rabies virus / Q000276:immunology; D014611:Vaccination / Q000662:veterinary*
chemical_list: D000914:Antibodies, Viral; D011819:Rabies Vaccines